US5574014A
(en)
*
|
1988-04-28 |
1996-11-12 |
Thrombosis Research Institute |
Inhibitors of trypsin-like enzymes
|
US6313096B1
(en)
|
1988-04-28 |
2001-11-06 |
Trigen Limited |
Inhibitors of trypsin-like enzymes
|
CA2080474A1
(en)
*
|
1990-04-14 |
1991-10-15 |
William W. Bachovchin |
Inhibitors of dipeptidyl-aminopeptidase type iv
|
US5462928A
(en)
*
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
DE69233671T2
(de)
*
|
1991-10-22 |
2007-10-18 |
New England Medical Center Hospitals, Inc., Boston |
Inhibitoren der Dipeptidyl-Aminopeptidase vom Typ IV
|
US6825169B1
(en)
*
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
MX9206628A
(es)
*
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
US6693072B2
(en)
*
|
1994-06-02 |
2004-02-17 |
Aventis Pharmaceuticals Inc. |
Elastase inhibitors
|
US5693515A
(en)
*
|
1995-04-28 |
1997-12-02 |
Arris Pharmaceutical Corporation |
Metal complexed serine protease inhibitors
|
US6255091B1
(en)
|
1995-04-28 |
2001-07-03 |
Axys Pharmaceuticals, Inc. |
Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
|
US20020006899A1
(en)
*
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
US5965532A
(en)
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
US6040145A
(en)
*
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
US6100234A
(en)
*
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
AU743996B2
(en)
*
|
1997-09-29 |
2002-02-14 |
Point Therapeutics, Inc. |
Stimulation of hematopoietic cells in vitro
|
AU2007202745B2
(en)
*
|
1998-02-02 |
2010-11-18 |
1149336 Ontario, Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
EP2574336A1
(en)
|
1998-02-02 |
2013-04-03 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
JP2002513762A
(ja)
*
|
1998-05-04 |
2002-05-14 |
ポイント セラピューティクス, インコーポレイテッド |
造血刺激
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
JP2002517401A
(ja)
*
|
1998-06-05 |
2002-06-18 |
ポイント セラピューティクス, インコーポレイテッド |
環状ボロプロリン化合物
|
DE19828114A1
(de)
*
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828113A1
(de)
*
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19834591A1
(de)
*
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
US6979697B1
(en)
*
|
1998-08-21 |
2005-12-27 |
Point Therapeutics, Inc. |
Regulation of substrate activity
|
US20030176357A1
(en)
*
|
1998-10-06 |
2003-09-18 |
Pospisilik Andrew J. |
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
|
US6890904B1
(en)
*
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
DE19926233C1
(de)
|
1999-06-10 |
2000-10-19 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Herstellung von Thiazolidin
|
DE19940130A1
(de)
*
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
PT1283735E
(pt)
|
2000-03-31 |
2009-03-19 |
Prosidion Ltd |
Processo para melhoramento da sinalização de ilhéus na diabetes mellitus e para a sua prevenção
|
US7132104B1
(en)
*
|
2000-10-27 |
2006-11-07 |
Probiodrug Ag |
Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
|
CN1278683C
(zh)
*
|
2000-10-27 |
2006-10-11 |
前体生物药物股份有限公司 |
二肽基肽酶iv抑制剂在制备治疗焦虑症的药物中的用途
|
JP4170758B2
(ja)
*
|
2001-01-16 |
2008-10-22 |
日本化薬株式会社 |
骨髄抑制治療剤、感染症治療剤及び白血球数増加剤
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
DE10150203A1
(de)
*
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
US20030130199A1
(en)
*
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
WO2003015768A2
(en)
*
|
2001-08-16 |
2003-02-27 |
Probiodrug Ag |
Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
|
US6844316B2
(en)
*
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
CA2837936A1
(en)
*
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
EP2769715A3
(en)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Methods for treating autoimmune disorders, and reagents related thereto
|
WO2003052440A2
(en)
*
|
2001-12-17 |
2003-06-26 |
Koninklijke Philips Electronics N.V. |
Magnetic resonance method
|
ATE349435T1
(de)
*
|
2002-02-28 |
2007-01-15 |
Prosidion Ltd |
Dpiv-inhibitoren auf glutaminbasis
|
US20030232761A1
(en)
*
|
2002-03-28 |
2003-12-18 |
Hinke Simon A. |
Novel analogues of glucose-dependent insulinotropic polypeptide
|
AU2003228793B2
(en)
*
|
2002-04-30 |
2008-01-03 |
Trustees Of Tufts College |
Smart Pro-Drugs of Serine Protease Inhibitors
|
AU2003248921A1
(en)
*
|
2002-07-09 |
2004-01-23 |
Point Therapeutics, Inc. |
Boroproline compound combination therapy
|
US20040033051A1
(en)
*
|
2002-08-16 |
2004-02-19 |
Ip Kiril Kun Wan |
Method and system for producing and displaying visual presentations which inhibit off-screen duplication
|
JP2006509034A
(ja)
|
2002-09-09 |
2006-03-16 |
トライジェン・リミテッド |
選択性トロンビン阻害のための非経口製剤に有用なボロン酸塩
|
US20050282757A1
(en)
*
|
2002-09-09 |
2005-12-22 |
Trigen Limited |
Peptide boronic acid compounds useful in anticoagulation
|
US20050119226A1
(en)
*
|
2003-09-09 |
2005-06-02 |
Trigen Limited |
Methods for synthesizing organoboronic compounds and products thereof
|
US7112572B2
(en)
*
|
2002-09-09 |
2006-09-26 |
Trigen Limited |
Multivalent metal salts of boronic acids
|
US20060084592A1
(en)
*
|
2002-09-09 |
2006-04-20 |
Trigen Limited |
Peptide boronic acid inhibitors
|
US20050176651A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
US20040058876A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Torsten Hoffmann |
Secondary binding site of dipeptidyl peptidase IV (DP IV)
|
EP1543023B1
(en)
*
|
2002-09-18 |
2010-03-17 |
Prosidion Limited |
Secondary binding site of dipeptidyl peptidase iv (dp iv)
|
CN1894234A
(zh)
*
|
2003-03-25 |
2007-01-10 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
ZA200508439B
(en)
*
|
2003-05-05 |
2007-03-28 |
Probiodrug Ag |
Medical use of inhibitors of glutaminyl and glutamate cyclases
|
KR20110059664A
(ko)
*
|
2003-05-05 |
2011-06-02 |
프로비오드룩 아게 |
글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
|
JP2007511467A
(ja)
|
2003-05-14 |
2007-05-10 |
タケダ サン ディエゴ インコーポレイテッド |
ジペプチジルペプチダーゼインヒビター
|
US7678909B1
(en)
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7470700B2
(en)
*
|
2003-08-13 |
2008-12-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP2007505121A
(ja)
*
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
US20050065144A1
(en)
*
|
2003-09-08 |
2005-03-24 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
JP5707014B2
(ja)
*
|
2003-10-15 |
2015-04-22 |
プロビオドルグ エージー |
グルタミニル、及びグルタミン酸シクラーゼのエフェクターの使用
|
US20100099721A1
(en)
*
|
2003-11-03 |
2010-04-22 |
Probiodrug Ag |
Novel compounds for the treatment of neurological disorders
|
US20050171112A1
(en)
*
|
2003-11-03 |
2005-08-04 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
US7674913B2
(en)
*
|
2003-11-12 |
2010-03-09 |
Phenomix Corporation |
Heterocyclic boronic acid compounds
|
US7317109B2
(en)
*
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
US7767828B2
(en)
*
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
US7576121B2
(en)
*
|
2003-11-12 |
2009-08-18 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
AU2005210004B2
(en)
|
2004-02-05 |
2010-10-28 |
Probiodrug Ag |
Novel inhibitors of glutaminyl cyclase
|
JP4781347B2
(ja)
*
|
2004-02-23 |
2011-09-28 |
トラスティーズ オブ タフツ カレッジ |
グルコース代謝を制御するためのペプチジルペプチダーゼiv阻害剤
|
GB0405272D0
(en)
*
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
BRPI0418639B8
(pt)
*
|
2004-03-15 |
2021-05-25 |
Takeda Pharmaceutical |
compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos
|
EP1753730A1
(en)
*
|
2004-06-04 |
2007-02-21 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
US20060063719A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Point Therapeutics, Inc. |
Methods for treating diabetes
|
WO2006034435A2
(en)
*
|
2004-09-21 |
2006-03-30 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
JP2008524331A
(ja)
*
|
2004-12-21 |
2008-07-10 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
US7329781B2
(en)
*
|
2005-02-24 |
2008-02-12 |
Stephen A. Westcott |
Methods of preparing main group boryl compounds
|
JP2008545661A
(ja)
*
|
2005-05-19 |
2008-12-18 |
ジェネンテック・インコーポレーテッド |
線維芽細胞活性化タンパク質阻害剤化合物および
|
US7825139B2
(en)
*
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
KR20080030079A
(ko)
*
|
2005-07-05 |
2008-04-03 |
트러스티즈 오브 터프츠 칼리지 |
섬유아세포 활성 단백질 알파의 억제제
|
US20070059382A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Board Of Regents, Univ. And Comm. College System Of Nevada... |
Medical treatment of breast cancer with boric acid materials
|
BRPI0616077B8
(pt)
*
|
2005-09-14 |
2021-05-25 |
Takeda Pharmaceuticals Co |
composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos
|
US20070060530A1
(en)
|
2005-09-14 |
2007-03-15 |
Christopher Ronald J |
Administration of dipeptidyl peptidase inhibitors
|
PE20070622A1
(es)
*
|
2005-09-14 |
2007-08-22 |
Takeda Pharmaceutical |
Administracion de inhibidores de dipeptidil peptidasa
|
CN102675221A
(zh)
|
2005-09-16 |
2012-09-19 |
武田药品工业株式会社 |
用于制备嘧啶二酮衍生物的方法中的中间体
|
TW200745080A
(en)
*
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
|
EP1948223A4
(en)
*
|
2005-10-07 |
2009-10-21 |
Biopharmica Ltd |
SUMOYLATION CONTROL AGENT AND APPLICATIONS
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2007109857A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Biopharmica Ltd |
Agent for the treatment of hormone-dependent disorders and uses thereof
|
US20090258827A1
(en)
|
2006-04-07 |
2009-10-15 |
Biopharmica Ltd. |
Transcription Factor Modulator
|
AR064235A1
(es)
*
|
2006-07-24 |
2009-03-25 |
Tetralogic Pharmaceuticals Cor |
Dipeptidos antagonistas de iap, una composicion farmaceutica que los comprende y el uso de los mismos para el tratamiento del cancer
|
AR062760A1
(es)
*
|
2006-09-13 |
2008-12-03 |
Takeda Pharmaceutical |
Administracion de inhibidores de dipeptidilpetidasa
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
US20100144140A1
(en)
*
|
2008-12-10 |
2010-06-10 |
Novellus Systems, Inc. |
Methods for depositing tungsten films having low resistivity for gapfill applications
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
HRP20221320T1
(hr)
|
2011-08-30 |
2023-01-06 |
Trustees Of Tufts College |
Fap-aktivirani inhibitori proteasoma za liječenje solidnih tumora
|
US9688722B2
(en)
*
|
2012-05-04 |
2017-06-27 |
The Board Of Regents Of The University Of Oklahoma |
Substrates and inhibitors of prolyl oligopeptidase and methods of use
|
US9523687B2
(en)
|
2014-02-28 |
2016-12-20 |
Institut Pasteur |
Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS
|
CN112645971B
(zh)
*
|
2021-01-20 |
2021-12-24 |
中国科学院兰州化学物理研究所 |
一种烷基卤代物直接制备烷基硼酸酯类化合物的方法
|